LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Techniques Compared for Diagnosis of Rickettsioses

By LabMedica International staff writers
Posted on 19 Mar 2012
Print article
The diagnosis and isolation of Rickettsia species from skin biopsies may be replaced by a real time polymerase chain reaction (rt-PCR).

Diagnosis of Rickettsia infection would benefit by use of the more rapid and sensitive method of quantitative rt-PCR than the time-intensive and less sensitive method of culturing Rickettsia species from skin biopsies.

Scientists at the University of the Mediterranean (Marseille, France) analyzed punch biopsies or scalpel incisions of eschars collected from patients with suspected rickettsial infections between January 2007 and January 2010. Patients were classified as definitely having rickettsiosis if there was direct evidence of infection with a Rickettsia species using culture or molecular assays or if serology was positive. Rickettsial diseases are zoonoses caused by obligate intracellular bacteria.

Total genomic DNA was extracted from samples using a QIAamp tissue kit (Qiagen, Hilden, Germany). Samples were screened for the presence of Rickettsia species using a previously developed rt-PCR assay targeting a 109 base pairs (bp) fragment of a hypothetical protein. Quantification of Rickettsia species were performed using serial ten-fold dilutions of R. africae, R. slovaca, R. raoultii, and R. helvetica. Bacteria were detected by indirect immunofluorescence using human serum and antiserum. All sera were tested by immunofluorescence (IF) for spotted fever group (SFG) rickettsial antigens. Samples were cultured in human embryonic lung (HEL) fibroblasts using the centrifugation-shell vial technique.

Rickettsia species infection was diagnosed in 47/145 (32%) skin biopsies from patients with suspected rickettsiosis. By rt-PCR a positive result was obtained for 41 skin biopsies (28.2%). Rickettsia africae was the most common detected species, followed by R. conorii conorii, R. slovaca, R. sibirica mongolitimonae, and R. raoultii. Comparison of culture and rt-PCR to serology was done for the 26 patients with suspected rickettsiosis with a skin biopsy that also had an acute serum and a convalescent-phase serum sample. The rt-PCR sensitivity was 82% as compared to serology whereas culture sensitivity was 29.4% as compared to serology.

The author concluded that for the diagnosis of Rickettsia infection the use of molecular and culture diagnostic tools, decreases the time of diagnosis and increases the sensitivity. However, a negative result using molecular assays does not exclude the diagnosis of Rickettsia infection. To increase the sensitivity of culture, skin biopsies should be sampled before treatment early in the course of the disease and should be inoculated as soon as possible. The study was published on March 6, 2012, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

University of the Mediterranean
Qiagen



Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Lyme Disease Test
Lyme IgG/IgM Rapid Test Cassette
New
Fecal DNA Extraction Kit
QIAamp PowerFecal Pro DNA Kit

Print article

Channels

Molecular Diagnostics

view channel
Image: The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test (Photo courtesy of Mirvie)

RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms

Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.